Refractory Acute Undifferentiated Leukemia

2 clinical trials · Condition

Record	Firm	Date
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia (NCT04375631)	Fred Hutchinson Cancer Center	2020-12-03

Every clearance here is in the API, with alerts when new ones post.